176 related articles for article (PubMed ID: 32618400)
1. Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections.
Baghel S; Nair VS; Pirani A; Sravani AB; Bhemisetty B; Ananthamurthy K; Aranjani JM; Lewis SA
Dermatol Ther; 2020 Nov; 33(6):e13959. PubMed ID: 32618400
[TBL] [Abstract][Full Text] [Related]
2. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations.
Mahmood A; Rapalli VK; Gorantla S; Waghule T; Singhvi G
Drug Deliv Transl Res; 2022 May; 12(5):1118-1135. PubMed ID: 33895936
[TBL] [Abstract][Full Text] [Related]
3. Curcuma Turmeric Oil Enhanced Anti-Dermatophytic Drug Activity Against Candida albicans and Trichophyton mentagrophytes.
Singh M; Alka ; Lee KE; Kumar P; Kang SG
Curr Drug Deliv; 2021; 18(10):1494-1504. PubMed ID: 34325638
[TBL] [Abstract][Full Text] [Related]
4. Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis.
Koga H; Nanjoh Y; Kaneda H; Yamaguchi H; Tsuboi R
Antimicrob Agents Chemother; 2012 Jun; 56(6):3138-43. PubMed ID: 22391525
[TBL] [Abstract][Full Text] [Related]
5. Luliconazole for the treatment of fungal infections: an evidence-based review.
Khanna D; Bharti S
Core Evid; 2014; 9():113-24. PubMed ID: 25285056
[TBL] [Abstract][Full Text] [Related]
6. Novel in vivo observations on double acting points of luliconazole on Trichophyton rubrum: an ultrastructural study.
Wakumoto-Nakashima K; Yamada N; Morino S; Yamamoto O
Med Mycol; 2015 Nov; 53(8):860-7. PubMed ID: 26316213
[TBL] [Abstract][Full Text] [Related]
7. Multipotentiality of Luliconazole against Various Fungal Strains: Novel Topical Formulations and Patent Review.
Mahajan A; Kaur L; Singh G; Dhawan RK; Singh L
Recent Adv Antiinfect Drug Discov; 2021; 16(3):182-195. PubMed ID: 34766898
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Efficacy of Berberine Hydrochloride-loaded Transethosomal Gel System in Treating Dermatophytosis Caused by Trichophyton Rubrum in ex-vivo, in-vitro, and in-vivo models.
Mishra KK; Kaur CD; Singh S; Tiwari A; Tiwari V; Sharma A
Curr Drug Res Rev; 2023 Jul; ():. PubMed ID: 37496248
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
[TBL] [Abstract][Full Text] [Related]
10. [In vitro Antifungal Activity of Luliconazole against Trichophyton spp].
Maeda J; Nanjoh Y; Koga H; Toga T; Makimura K; Tsuboi R
Med Mycol J; 2016; 57(1):J1-6. PubMed ID: 26936346
[TBL] [Abstract][Full Text] [Related]
11. A Case of Tinea Pseudoimbricata Due to Trichophyton tonsurans Induced by Topical Steroid Application.
Suzuki T; Sato T; Horikawa H; Kasuya A; Yaguchi T
Med Mycol J; 2021; 62(4):67-70. PubMed ID: 34853252
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes.
Na YG; Huh HW; Kim MK; Byeon JJ; Han MG; Lee HK; Cho CW
Acta Biomater; 2020 Jan; 101():507-518. PubMed ID: 31629894
[TBL] [Abstract][Full Text] [Related]
13. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris.
Jones TM; Jarratt MT; Mendez-Moguel I; Paz N; Grekin SK; Cognata Smith C; Kaur M
J Drugs Dermatol; 2014 Jan; 13(1):32-8. PubMed ID: 24385117
[TBL] [Abstract][Full Text] [Related]
14. Once-daily luliconazole cream 1% for the treatment of interdigital tinea pedis.
Gold MH; Olin JT
Expert Rev Anti Infect Ther; 2015; 13(12):1433-40. PubMed ID: 26559086
[TBL] [Abstract][Full Text] [Related]
15. Development and Optimization of Luliconazole Nanostructured Lipid Carriers Based Gel by Quality by Design its Skin Distribution Studies, Dermatokinetic Modeling & In-Vitro and Ex-Vivo Correlation.
Bhargav E; Reddy YP; Koteshwara KB
Curr Drug Deliv; 2021; 18(7):1041-1053. PubMed ID: 33319682
[TBL] [Abstract][Full Text] [Related]
16. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carrier-incorporated gel for efficient topical delivery of fluconazole.
Patil A; Tuencar V; Gadad A; Dandagi P; Masareddy R
Ther Deliv; 2021 Aug; 12(8):565-574. PubMed ID: 34187177
[No Abstract] [Full Text] [Related]
18. Development and evaluation of ultra-small nanostructured lipid carriers: novel topical delivery system for athlete's foot.
Singh S; Singh M; Tripathi CB; Arya M; Saraf SA
Drug Deliv Transl Res; 2016 Feb; 6(1):38-47. PubMed ID: 26542152
[TBL] [Abstract][Full Text] [Related]
19. Luliconazole vesicular based gel formulations for its enhanced topical delivery.
Kaur M; Singh K; Jain SK
J Liposome Res; 2020 Dec; 30(4):388-406. PubMed ID: 31631734
[TBL] [Abstract][Full Text] [Related]
20. New Antifungal Agents and New Formulations Against Dermatophytes.
Gupta AK; Foley KA; Versteeg SG
Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
